Anticoagulants with antiplatelets 'questionable' in some with AF

Large registry study suggests higher risk of stroke and bleeding on dual therapy

To their possible detriment, a sizable minority of patients with non-valvular AF are receiving oral anticoagulants (OAC) in addition to antiplatelet drugs, according to data from an AF registry.